SCHEMBL12801072

SCHEMBL12801072

COc1ccc(-c2ccnc(Nc3cccc(NC(=O)OC(C)(C)C)c3)n2)cc1N

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 7/20 0.54
BCR P11274 7/20 0.54
PDGFRB P09619 2/20 0.54
PDGFRA P16234 2/20 0.54
PRKCA P17252 2/20 0.54
EGFR P00533 1/20 0.54
CDK5 Q00535 2/20 0.51
JAK2 O60674 3/20 0.50
FLT3 P36888 1/20 0.50
SYK P43405 1/20 0.49
PIK3CG P48736 4/20 0.48
PIK3CA P42336 3/20 0.48
PIK3CB P42338 3/20 0.48
AAK1 Q2M2I8 2/20 0.48
ABL2 P42684 1/20 0.48
PLK1 P53350 1/20 0.47
SRC P12931 2/20 0.46
PRKCD Q05655 1/20 0.46
MEN1 O00255 1/20 0.46
NPC1 O15118 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12801194 0.90 AAK1 (0.47) ABL1BCRPDGFRBPDGFRAPRKCA
SCHEMBL12801096 0.89 JAK2 (0.61) ABL1BCRPDGFRBPDGFRAPRKCA
SCHEMBL12522328 0.88 AAK1 (0.57) ABL1BCRPDGFRBPDGFRAPRKCA
SCHEMBL12801324 0.83 PDPK1 (0.59) ABL1BCRPDGFRBPDGFRAPRKCA
SCHEMBL12522222 0.83 ABL1 (0.51) ABL1BCRPDGFRBPDGFRAPRKCA
SCHEMBL12801118 0.82 CDK5 (0.73) ABL1BCRPRKCAEGFRCDK5
SCHEMBL12801697 0.81 ABL1 (0.50) ABL1BCRPDGFRBPDGFRAPRKCA
SCHEMBL12801601 0.81 ABL1 (0.50) ABL1BCRPDGFRBPDGFRAPRKCA
SCHEMBL14253949 0.81 PIK3CG (0.73) ABL1BCREGFRCDK5JAK2
SCHEMBL14253944 0.81 IKBKB (0.61) ABL1PRKCAEGFRCDK5JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011046970-A1 AMINO - PYRIMIDINE COMPOUNDS AS INHIBITORS OF TBKL AND/OR IKK EPSILON MYREXIS, INC. (US) 2011-04-21 WO disclosed